ContextLogic Holdings Q1 net income jumps on tax benefit
LogicBio Therapeutics LOGC | 0.00 |
Overview
US niche business platform's Q1 revenue flat yr/yr after US Salt acquisition
Q1 net income rose sharply, driven by a $41.9 mln tax benefit from acquisition
Adjusted EBITDA for Q1 declined due to new parent-level costs
Outlook
Company did not provide specific financial guidance for the current quarter or full year in its release
Result Drivers
VOLUME DECLINE - Shipped volumes fell 7% due to trucking disruptions from winter storms and temporary operational interruptions at the Watkins Glen facility
HIGHER SELLING PRICES - 8% growth in average selling price offset lower volumes, driven by price increases and product mix shift
CORPORATE COSTS - Adjusted EBITDA declined due to approximately $1 mln of parent-level costs not present in the prior-year period
Company press release: ID:nGNX1rcsqZ
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
|
$32.40 mln |
|
Q1 Net Income |
|
$17 mln |
|
Q1 Adjusted EBITDA |
|
$11.60 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
